Gentag believes that wearable biosensors linked with NFC devices have the power to transform medical and consumer diagnostics. We first patented the concept of an electronic “second skin” over a decade ago.
From the National Labs to Hospitals and Homes
Radar Responsive Tags, a sophisticated geolocation and tracking technology, are capable of precision locating items or individuals over large areas. First developed at the US National Laboratories for the Department of Defense, these tiny wireless chips, combined with sensors, are capable of providing exquisite location services.
This is a text block. Click the edit button to change this text.
Working to reduce costly hospital readmissions
By linking patients, wearable biological sensors that can be read with an encrypted NFC device, and doctors or hospitals, Gentag is working to reduce costly hospital readmissions, simplify patient discharge, and enable easy in-home self-monitoring.
Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and DiabetesMarch 4, 2015Read more
ROCHESTER, Minn. — Mayo Clinic and Gentag, Inc. have reached an agreement to develop the next generation of wearable biosensors designed to fight obesity and diabetes. “We are hoping that this technology will be game-changer. These patch biosensors may help us reduce global obesity and diabetes,” says James Levine, M.D., Ph.D., a Mayo Clinic endocrinologist and obesity researcher. “They are accurate, inexpensive, and can be integrated into the care people receive.” A first-of-its-kind, the wearable patch sensors are the size of a small bandage, and are designed to be painless, wireless and disposable. In the bandage is a sensor that communicates via a closed-loop diabetes...
- October 28, 2014Read more
Skaneateles, NY, and Washington, DC, October 28, 2014 — Welch Allyn, a leading medical diagnostic device company that delivers pragmatic innovation at the point of care, and Gentag, Inc., a pioneer in disposable biosensors that can be read with near field communication (NFC) devices, announced today that they have entered into a strategic development agreement. Under the terms of the agreement, Welch Allyn and Gentag will bring to market near field communication technology for medical devices and sensors. The partnership with Gentag enables Welch Allyn to continue providing innovative solutions in medical settings, and NFC will allow the extension...
Wearables for Diagnostics: Gentag’s Disposable NFC Biomarker Patent Receives Notice of Allowance from the European Patent OfficeSeptember 9, 2014Read more
WASHINGTON, DC Sept. 9, 2014 – Gentag, Inc. is pleased to announce that it has been granted a new, additional allowance for its patents in Europe. This allowance, granted by the European Patent Office, further enhances the company’s already significant intellectual property holdings of near field communication (NFC) mobile phone sensor technologies and complements its disposable wearable NFC sensor patent portfolio. The new patent covers quantitative diagnostic tests that can be carried out anywhere – no lab, or costly lab work, needed – using NFC-enabled mobile phones. Multiple diagnostic tests are possible using just a single drop of blood or urine. The...